VeryDiab
Store data observed · From public App Store data · How we score apps
- Medical
- App Store
- United States
- —0 ratings
- Paid $1.99
- Updated
- Observed
Ratings
Observed0
Chart position
Observed—Not on the top charts
90-day growth
—not enough history yet
Opportunity score
AI-derived11/100Weak · low confidence
Own VeryDiab? Share your real numbers
Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.
Sign in to share them.
Made VeryDiab? Add a “Tracked in Medical” badge to your site
About VeryDiabObserved
VeryDiab is a Medical app by Veryphone on the United States App Store. Released Aug 28, 2012; last updated Jul 13, 2021 (version 2.70). VeryDiab costs $1.99 to download.
MRRBeam rates the success of VeryDiab 0/100 (early stage).
VeryDiab is your diabetes diary always at hand. Record the results of your blood glucose, your insulin injections, meals and carbohydrate intake and your physical activities. All this informations will be included in your self-monitoring diary and you can show or send them to your doctor.
- Success score
- 0/100 Early stage
- In Medical
- Outside the top 100
- Chart position
- Not on the top charts
- Developer
- Veryphone
Loading the full report…
VeryDiab: common questions
- What is VeryDiab?
- VeryDiab is a Medical app developed by Veryphone, available on the App Store. It was first released on Aug 28, 2012.
- How much does VeryDiab cost?
- VeryDiab costs $1.99 to download.
- Is VeryDiab successful?
- MRRBeam rates the success of VeryDiab 0/100 (early stage). The success score combines rating volume, chart position and average rating.
- When was VeryDiab last updated?
- VeryDiab was last updated on Jul 13, 2021 (version 2.70).
- What are alternatives to VeryDiab?
- Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
- Is there room to build a competitor to VeryDiab?
- MRRBeam's opportunity score for VeryDiab is 11/100. Limited opening: an older app, little observable demand and low price points.